SCHEMBL16715087

SCHEMBL16715087

CCSc1ccc(Cl)cc1N(N)C(=O)c1cc(C)cc(Br)c1N

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ DDR1 Q08345 2/20 0.38
▸ TP53 P04637 1/20 0.32
▸ RXFP1 Q9HBX9 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ MAPT P10636 3/20 0.31
▸ GAA P10253 1/20 0.31
▸ RECQL P46063 1/20 0.31
▸ POLB P06746 1/20 0.31
▸ ALDH1A1 P00352 3/20 0.31
▸ MEN1 O00255 2/20 0.31
▸ KMT2A Q03164 2/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ CYP3A4 P08684 1/20 0.30
▸ P2RX1 P51575 1/20 0.30
▸ TMPRSS4 Q9NRS4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16529560 0.75 DDR1 (0.39) DDR1TP53MAPTGAAALDH1A1
SCHEMBL16529626 0.75 DDR1 (0.54) DDR1HPGDRECQLALDH1A1
SCHEMBL16715079 0.73 DDR1 (0.44) DDR1TMPRSS4
SCHEMBL16529561 0.72 DDR1 (0.36) DDR1TP53HPGDMAPTALDH1A1
SCHEMBL16676499 0.69 GAA (0.38) DDR1TP53RXFP1MAPTGAA
SCHEMBL16676293 0.66 DDR1 (0.38) DDR1MEN1KMT2ACYP3A4
SCHEMBL16676266 0.66 GAA (0.43) MAPTGAAALDH1A1MEN1KMT2A
SCHEMBL28073062 0.66 PSEN1 (0.35) DDR1MAPTRAB9ASMN1; SMN2
SCHEMBL31392512 0.64 KDM4E (0.42) HTTMAPTALDH1A1MEN1KMT2A
SCHEMBL16676508 0.63 GAA (0.37) DDR1TP53MAPTGAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150141400-A1 QUINAZOLINEDIONE DERIVATIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2015-05-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150141400-A1 QUINAZOLINEDIONE DERIVATIVE PPARD, SLC5A2, PPARG DDR1 2764/4885TP53 2407/4885RXFP1 969/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback